Digital ulcers (DU) are a common clinical problem in systemic sclerosis (SSc); however, there is no standardization of local wound care protocols for management of these lesions. There is a well-recognized need to develop and standardize non-pharmacological management of DU in patients with SSc, and to adopt these protocols in future clinical trials that focus on DU healing. The purpose of this review is to outline the types of DU that occur in SSc, and provide an update on the principles of wound management for these lesions based on the current literature and expert opinion.
HachullaEClersonPLaunayDet al. Natural history of ischemic digital ulcers in systemic sclerosis: single-center retrospective longitudinal study. J Rheumatol. 2007;34(12):2423-2430.
3.
AbrahamSSteenV.Optimal management of digital ulcers in systemic sclerosis. Ther Clin Risk Manag. 2015;11:939-947.
Müller-LadnerUDistlerOIbba-ManneschiLNeumannEGayS.Mechanisms of vascular damage in systemic sclerosis. Autoimmunity. 2009;42(7):587-595.
6.
BaronMPopeJRobinsonDet al. Calcinosis is associated with digital ischaemia in systemic sclerosis-a longitudinal study. Rheumatology (Oxford). 2016;55(12):2148-2155.
7.
SulimanYABruniCJohnsonSRet al. Defining skin ulcers in systemic sclerosis: systematic literature review and proposed World Scleroderma Foundation (WSF) definition. J Scleroderma Relat Disord. 2017;2(2):115-120.
8.
SilvaITeixeiraAOliveiraJet al. Endothelial dysfunction and nailfold videocapillaroscopy pattern as predictors of digital ulcers in systemic sclerosis: a cohort study and review of the literature. Clin Rev Allergy Immunol. 2015;49(2):240-252.
9.
SilvaITeixeiraAOliveiraJAlmeidaIAlmeidaRVasconcelosC.Predictive value of vascular disease biomarkers for digital ulcers in systemic sclerosis patients. Clin Exp Rheumatol. 2015;33(4)(Suppl 91):S127-S130.
10.
BaronMChungLGygerGet al. Consensus opinion of a North American Working Group regarding the classification of digital ulcers in systemic sclerosis. Clin Rheumatol. 2014;33(2):207-214.
11.
AvouacJRiemekastenGMeuneCRuizBKahanAAllanoreY.Autoantibodies against Endothelin 1 Type A Receptor Are Strong Predictors of Digital Ulcers in Systemic Sclerosis. J Rheumatol. 2015;42(10):1801-1807.
12.
MurrayAKMooreTLWraggEet al. Pilot study assessing pathophysiology and healing of digital ulcers in patients with systemic sclerosis using laser Doppler imaging and thermography. Clin Exp Rheumatol. 2016;34 Suppl100(5):100-105.
13.
FrechTWalkerAEBarrett-OKeefeZet al. Systemic sclerosis induces pronounced peripheral vascular dysfunction characterized by blunted peripheral vasoreactivity and endothelial dysfunction. Clin Rheumatol. 2015;34(5):905-913.
14.
BoseNBenaJChatterjeeS.Evaluation of the effect of ambrisentan on digital microvascular flow in patients with systemic sclerosis using laser Doppler perfusion imaging: a 12-week randomized double-blind placebo controlled trial. Arthritis Res Ther. 2015;17(1):44.
15.
HughesMMooreTManningJet al. Reduced perfusion in systemic sclerosis digital ulcers (both fingertip and extensor) can be increased by topical application of glyceryl trinitrate. Microvasc Res. 2017;111:32-36.
16.
FrerixMStegbauerJDragunDKreuterAWeinerSM.Ulnar artery occlusion is predictive of digital ulcers in SSc: a duplex sonography study. Rheumatology (Oxford). 2012;51(4):735-742.
17.
HerrickAL.Recent advances in the pathogenesis and management of Raynauds phenomenon and digital ulcers. Curr Opin Rheumatol. 2016;28(6):577-585.
18.
AmanziLBraschiFFioriGet al. Digital ulcers in scleroderma: staging, characteristics and sub-setting through observation of 1614 digital lesions. Rheumatology (Oxford). 2010;49(7):1374-1382.
19.
MoranME.Scleroderma and evidence based non-pharmaceutical treatment modalities for digital ulcers: a systematic review. J Wound Care. 2014;23(10):510-516.
GarwoodCSSteinbergJS.What’s new in wound treatment: a critical appraisal. Diabetes Metab Res Rev. 2016;32(Suppl 1):268-274.
23.
ShanmugamVKPricePAttingerCESteenVD.Lower extremity ulcers in systemic sclerosis: features and response to therapy. Int J Rheumatol. 2010;2010:747946.
24.
MilneJ.Wound-bed preparation: the importance of rapid and effective desloughing to promote healing. Br J Nurs. 2015;24(Sup20)(Suppl 20):S52-S58.
25.
JiaSZhaoYLawMGalianoRMustoeTA. The effects of collagenase ointment on the prevention of hypertrophic scarring in a rabbit ear scarring model: a pilot study. Wounds. 2011;23(6):160-165.
26.
JiaSZhaoYLawMGalianoRDMustoeTA. The effect of collagenase on ischemic wound healing: results of an in vivo study. Ostomy Wound Manage. 2011;57(8):20-26.
27.
FioriGGalluccioFBraschiFet al. Vitamin E gel reduces time of healing of digital ulcers in systemic sclerosis. Clin Exp Rheumatol. 2009;27(3)(Suppl 54):51-54.
28.
PilcherM.Wound cleansing: a key player in the implementation of the TIME paradigm. J Wound Care. 2016;25(3)(Suppl):S7-S9.
29.
BarnesSSpencerMGrahamDJohnsonHB.Surgical wound irrigation: a call for evidence-based standardization of practice. Am J Infect Control. 2014;42(5):525-529.
30.
NiezgodaJASordiPJHermansMH.Evaluation of Vashe Wound Therapy in the clinical management of patients with chronic wounds. Adv Skin Wound Care. 2010;23(8):352-357.
31.
WeeksLEIIISchekerLR.Upper extremity wound management. J Ky Med Assoc. 1990;88(7):337-341.
32.
AgostinhoAMHartmanALippCParkerAEStewartPSJamesGA.An in vitro model for the growth and analysis of chronic wound MRSA biofilms. J Appl Microbiol. 2011;111(5):1275-1282.
33.
BiglariBvd LindenPHSimonAAytacSGernerHJMoghaddamA.Use of Medihoney as a non-surgical therapy for chronic pressure ulcers in patients with spinal cord injury. Spinal Cord. 2012;50(2):165-169.
34.
CooperRJenkinsLHooperS.Inhibition of biofilms of Pseudomonas aeruginosa by Medihoney in vitro. J Wound Care. 2014;23(3):93-96, 98-100.
35.
RobsonVDoddSThomasS.Standardized antibacterial honey (Medihoney) with standard therapy in wound care: randomized clinical trial. J Adv Nurs. 2009;65(3):565-575.
36.
OMearaSAl-KurdiDOlogunYOvingtonLGMartyn-St JamesMRichardsonR.Antibiotics and antiseptics for venous leg ulcers. Cochrane Database Syst Rev. 2014;(1):CD003557.
37.
KavrosSJMillerJLHannaSW.Treatment of ischemic wounds with noncontact, low-frequency ultrasound: the Mayo clinic experience, 20042006. Adv Skin Wound Care. 2007;20(4):221-226.
38.
FlemingCP.Acoustic pressure wound therapy in the treatment of a vasculopathy-associated digital ulcer: a case study. Ostomy Wound Manage. 2008;54(4):62-65.
39.
AdubaDCYangH.Polysaccharide fabrication platforms and biocompatibility assessment as candidate wound dressing materials. Bioengineering (Basel). 2017;4(1). pii: E1.
40.
GabisonSMcGillivrayCHitzigSLNussbaumE.A study of the utility and equivalency of 2 methods of wound measurement: digitized tracing versus digital photography. Adv Skin Wound Care. 2015;28(6):252-258.
41.
WillemsLMRedmondACStammTAet al. Content of non-pharmacological care for systemic sclerosis and educational needs of European health professionals: a EUSHNet survey. Clin Exp Rheumatol. 2015;33(4)(Suppl 91):S153-S159.
42.
Kowal-BieleckaOFransenJAvouacJet al. Update of EULAR recommendations for the treatment of systemic sclerosis. Ann Rheum Dis. 2016.
43.
HughesMOngVHAndersonMEet al. Consensus best practice pathway of the UK Scleroderma Study Group: digital vasculopathy in systemic sclerosis. Rheumatology (Oxford). 2015;54(11):2015-2024.
44.
ShenoyPDKumarSJhaLKet al. Efficacy of tadalafil in secondary Raynauds phenomenon resistant to vasodilator therapy: a double-blind randomized cross-over trial. Rheumatology (Oxford). 2010;49(12):2420-2428.
45.
HachullaEHatronPYCarpentierPet al. SEDUCE study group. Efficacy of sildenafil on ischaemic digital ulcer healing in systemic sclerosis: the placebo-controlled SEDUCE study. Ann Rheum Dis. 2016;75(6):1009-1015.
46.
Matucci-CerinicMDentonCPFurstDEet al. Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial. Ann Rheum Dis. 2011;70(1):32-38.
47.
ShahAASchiopuEHummersLKet al. Open label study of escalating doses of oral treprostinil diethanolamine in patients with systemic sclerosis and digital ischemia: pharmacokinetics and correlation with digital perfusion. Arthritis Res Ther. 2013;15(2):R54.
48.
FotiRVisalliEAmatoGet al. Long-term clinical stabilization of scleroderma patients treated with a chronic and intensive IV iloprost regimen. Rheumatol Int. 2017;37(2):245-249.
49.
MomeniASoriceSCValenzuelaAFiorentinoDFChungLChangJ.Surgical treatment of systemic sclerosis it justified to offer peripheral sympathectomy earlier in the disease process?Microsurgery. 2015;35(6):441-446.
50.
ŻebrykPPuszczewiczMJ.Botulinum toxin A in the treatment of Raynauds phenomenon: a systematic review. Arch Med Sci. 2016;12(4):864-870.
51.
Del PapaNDi LucaGSambataroDet al. Regional implantation of autologous adipose tissue-derived cells induces a prompt healing of long-lasting indolent digital ulcers in patients with systemic sclerosis. Cell Transplant. 2015;24(11):2297-2305.
52.
RoustitMBlaiseSCracowskiJL.Trials and tribulations of skin iontophoresis in therapeutics. Br J Clin Pharmacol. 2014;77(1):63-71.
53.
SaitoSIshiiTKamogawaYet al. Extracorporeal shock wave therapy for digital ulcers of systemic sclerosis: a phase 2 pilot study. Tohoku J Exp Med. 2016;238(1):39-47.
54.
UghiNCrottiCIngegnoliF.Effectiveness and safety of oxycodone/naloxone in the management of chronic pain in patients with systemic sclerosis with recurrent digital ulcers: two case reports. Clin Interv Aging. 2016;11:307-311.
55.
BraschiFBartoliFBruniCet al. Lidocaine controls pain and allows safe wound bed preparation and debridement of digital ulcers in systemic sclerosis: a retrospective study. Clin Rheumatol. 2017;36(1):209-212.
56.
ShanmugamVKCouchKSMcNishSAmdurRL.Relationship between Opioid Treatment and Rate of Healing in Chronic Wounds. Wound Repair Regen. 2016.
PooleJL.Musculoskeletal rehabilitation in the person with scleroderma. Curr Opin Rheumatol. 2010;22(2):205-212.
59.
PaulingJDFrechTMDomsicRTHudsonM.Patient participation in patient-reported outcome instrument development in systemic sclerosis. Clin Exp Rheumatol. 2017.
